Select Publications
Book Chapters
2022, '2.12 - Changes in Gut Microbiota Due to Gastrointestinal Surgery', in Comprehensive Gut Microbiota, pp. 139 - 144, http://dx.doi.org/10.1016/B978-0-12-819265-8.00075-9
,2018, 'Molecular analysis of the microbiome in colorectal cancer', in Colorectal Cancer, Springer, pp. 139 - 153, http://dx.doi.org/10.1007/978-1-4939-7765-9_8
,2016, 'Influence of host gene polymorphisms on development of gastroduodenal diseases', in Helicobacter pylori Research: From Bench to Bedside, pp. 339 - 362, http://dx.doi.org/10.1007/978-4-431-55936-8_14
,2011, 'The Molecular Basis of Lipid A and Toll-Like Receptor 4 Interactions', in Knirel YA; Valvano MA (ed.), BACTERIAL LIPOPOLYSACCHARIDES: STRUCTURE, CHEMICAL SYNTHESIS, BIOGENESIS AND INTERACTION WITH HOST CELLS, SPRINGER-VERLAG WIEN, pp. 371 - 387, http://dx.doi.org/10.1007/978-3-7091-0733-1_12
,Journal articles
2024, 'Optimised human stool sample collection for multi-omic microbiota analysis', Scientific Reports, 14, http://dx.doi.org/10.1038/s41598-024-67499-4
,2024, 'The circulating methylome in childhood-onset inflammatory bowel disease.', J Crohns Colitis, http://dx.doi.org/10.1093/ecco-jcc/jjae157
,2024, 'Dietary Emulsifier Exposure in People with Inflammatory Bowel Disease Compared with Healthy Controls: Is There a Cause for Concern?', Inflammatory Bowel Diseases, 30, pp. 1241 - 1250, http://dx.doi.org/10.1093/ibd/izad318
,2024, 'Switching from Dose-Intensified intravenous to SubCutaneoUS infliximab in Inflammatory Bowel Disease (DISCUS-IBD): protocol for a multicentre randomised controlled trial', BMJ Open, 14, http://dx.doi.org/10.1136/bmjopen-2023-081787
,2024, 'Prebiotic selection influencing inflammatory bowel disease treatment outcomes: A review of the preclinical and clinical evidence', eGastroenterology, 2, http://dx.doi.org/10.1136/egastro-2023-100055
,2024, 'Pathogenesis and precision medicine for predicting response in inflammatory bowel disease: Advances and future directions', eGastroenterology, 2, http://dx.doi.org/10.1136/egastro-2023-100006
,2024, 'Positive relationship between plant diversity dietary patterns and disease activity in Australian adults with Inflammatory Bowel Disease', Proceedings of the Nutrition Society, 83, http://dx.doi.org/10.1017/s0029665124000867
,2024, 'Sa1887 IS DIVERSITY IMPORTANT IN THE GUT MICROBIOME AT IBD ONSET? A SYSTEMATIC REVIEW OF THE LITERATURE AND META-ANALYSIS OF ALPHA-DIVERSITY DATA', Gastroenterology, 166, http://dx.doi.org/10.1016/s0016-5085(24)01772-4
,2023, 'Mucin-microbiome signatures shape the tumor microenvironment in gastric cancer', Microbiome, 11, http://dx.doi.org/10.1186/s40168-023-01534-w
,2023, 'HLA-DP on Epithelial Cells Enables Tissue Damage by NKp44+ Natural Killer Cells in Ulcerative Colitis', Gastroenterology, 165, pp. 946 - 962.e13, http://dx.doi.org/10.1053/j.gastro.2023.06.034
,2023, 'A systematic review, pairwise meta-analysis and network meta-analysis of randomized controlled trials exploring the role of fecal microbiota transplantation in irritable bowel syndrome', European Journal of Gastroenterology and Hepatology, 35, pp. 471 - 479, http://dx.doi.org/10.1097/MEG.0000000000002519
,2023, 'Assessing the Relationship between the Gut Microbiota and Inflammatory Bowel Disease Therapeutics: A Systematic Review', Pathogens, 12, http://dx.doi.org/10.3390/pathogens12020262
,2023, 'Critical Assessment of Whole Genome and Viral Enrichment Shotgun Metagenome on the Characterization of Stool Total Virome in Hepatocellular Carcinoma Patients', Viruses, 15, pp. 53, http://dx.doi.org/10.3390/v15010053
,2023, 'Sa1865 MUCIN-MICROBIOME SIGNATURES SHAPE THE TUMOUR MICROENVIRONMENT IN GASTRIC CANCER', Gastroenterology, 164, pp. S - 468, http://dx.doi.org/10.1016/s0016-5085(23)02079-6
,2022, 'The role of the microbiome in the metabolic health of people with schizophrenia and related psychoses: cross-sectional and pre-post lifestyle intervention analyses', Pathogens, 11, pp. 1279, http://dx.doi.org/10.3390/pathogens11111279
,2022, 'Therapeutic Drug Monitoring of Subcutaneous Infliximab in Inflammatory Bowel Disease—Understanding Pharmacokinetics and Exposure Response Relationships in a New Era of Subcutaneous Biologics', Journal of Clinical Medicine, 11, http://dx.doi.org/10.3390/jcm11206173
,2022, 'Comprehensive Study of Antiretroviral Drug Permeability at the Cervicovaginal Mucosa via an In Vitro Model', Pharmaceutics, 14, http://dx.doi.org/10.3390/pharmaceutics14091938
,2022, 'Review article: the future of microbiome-based therapeutics', Alimentary Pharmacology and Therapeutics, 56, pp. 192 - 208, http://dx.doi.org/10.1111/apt.17049
,2022, 'The role of mucins in gastrointestinal barrier function during health and disease', The Lancet Gastroenterology and Hepatology, 7, pp. 455 - 471, http://dx.doi.org/10.1016/S2468-1253(21)00431-3
,2022, 'Redefining intestinal immunity with single-cell transcriptomics', Mucosal Immunology, 15, pp. 531 - 541, http://dx.doi.org/10.1038/s41385-021-00470-y
,2022, 'Correction to: Redefining intestinal immunity with single-cell transcriptomics (Mucosal Immunology, (2021), 10.1038/s41385-021-00470-y)', Mucosal Immunology, 15, pp. 526 - 526, http://dx.doi.org/10.1038/s41385-022-00483-1
,2022, 'Refining a Protocol for Faecal Microbiota Engraftment in Animal Models After Successful Antibiotic-Induced Gut Decontamination', Frontiers in Medicine, 9, http://dx.doi.org/10.3389/fmed.2022.770017
,2022, 'Gut Mucosal Microbiome Signatures of Colorectal Cancer Differ According to BMI Status', Frontiers in Medicine, 8, http://dx.doi.org/10.3389/fmed.2021.800566
,2022, 'The Role of Microbiota in Gastrointestinal Cancer and Cancer Treatment: Chance or Curse?', Cellular and Molecular Gastroenterology and Hepatology, 13, pp. 857 - 874, http://dx.doi.org/10.1016/j.jcmgh.2021.08.013
,2021, 'Inflammatory bowel disease and the gut microbiota', Proceedings of the Nutrition Society, 80, pp. 424 - 434, http://dx.doi.org/10.1017/S002966512100197X
,2021, 'Next-generation sequencing as a clinical laboratory tool for describing different microbiotas: An urgent need for future paediatric practice', Archives of Disease in Childhood, 106, pp. 1035, http://dx.doi.org/10.1136/archdischild-2021-321683
,2021, 'Systematic review with meta-analysis: dietary intake in adults with inflammatory bowel disease', Alimentary Pharmacology and Therapeutics, 54, pp. 742 - 754, http://dx.doi.org/10.1111/apt.16549
,2021, 'The Impact of NOD2 Genetic Variants on the Gut Mycobiota in Crohn's Disease Patients in Remission and in Individuals without Gastrointestinal Inflammation', Journal of Crohn's and Colitis, 15, pp. 800 - 812, http://dx.doi.org/10.1093/ecco-jcc/jjaa220
,2021, 'Biopsy Sampling in Upper Gastrointestinal Endoscopy: A Survey from 10 Tertiary Referral Centres across Europe', Digestive Diseases, 39, pp. 179 - 189, http://dx.doi.org/10.1159/000511867
,2021, 'Long‐term iron deficiency and dietary iron excess exacerbate acute dextran sodium sulphate‐induced colitis and are associated with significant dysbiosis', International Journal of Molecular Sciences, 22, http://dx.doi.org/10.3390/ijms22073646
,2021, 'A standardised model for stool banking for faecal microbiota transplantation: a consensus report from a multidisciplinary UEG working group', United European Gastroenterology Journal, 9, pp. 229 - 247, http://dx.doi.org/10.1177/2050640620967898
,2021, 'Australia IBD Microbiome (AIM) Study: Protocol for a multicentre longitudinal prospective cohort study', BMJ Open, 11, http://dx.doi.org/10.1136/bmjopen-2020-042493
,2020, 'Microbiome Understanding in Maternity Study (MUMS), an Australian prospective longitudinal cohort study of maternal and infant microbiota: study protocol', BMJ open, 10, pp. e040189, http://dx.doi.org/10.1136/bmjopen-2020-040189
,2020, 'First Case of Covid-19 in the United States', The New England journal of medicine, 382, pp. e53, http://dx.doi.org/10.1056/NEJMc2004794
,2020, 'Autism Spectrum Disorder and the Gut Microbiota in Children: A Systematic Review', Annals of Nutrition and Metabolism, 76, pp. 16 - 29, http://dx.doi.org/10.1159/000505363
,2020, 'Systematic review: gastric microbiota in health and disease', Alimentary Pharmacology and Therapeutics, 51, pp. 582 - 602, http://dx.doi.org/10.1111/apt.15650
,2020, 'Propionic Acid Promotes the Virulent Phenotype of Crohn's Disease-Associated Adherent-Invasive Escherichia coli', Cell Reports, 30, pp. 2297 - 2305.e5, http://dx.doi.org/10.1016/j.celrep.2020.01.078
,2019, 'Stool for fecal microbiota transplantation should be classified as a transplant product and not as a drug', UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 7, pp. 1408 - 1410, http://dx.doi.org/10.1177/2050640619887579
,2019, 'Draft genome sequences of a Campylobacter curvus and three Campylobacter ureolyticus strains isolated from human colonic mucosal tissue', Microbiota in Health and Disease, 1, pp. e148 - e148, http://dx.doi.org/10.26355/mhd_201911_148
,2019, 'A network meta-analysis of randomized controlled trials exploring the role of fecal microbiota transplantation in recurrent Clostridium difficile infection', United European Gastroenterology Journal, 7, pp. 1051 - 1063, http://dx.doi.org/10.1177/2050640619854587
,2019, 'Gut microbial biofilm composition and organisation holds the key to CRC', Nature Reviews Gastroenterology and Hepatology, 16, pp. 329 - 330, http://dx.doi.org/10.1038/s41575-019-0148-4
,2019, 'Inflammation associated ethanolamine facilitates infection by Crohn's disease-linked adherent-invasive Escherichia coli', EBioMedicine, 43, pp. 325 - 332, http://dx.doi.org/10.1016/j.ebiom.2019.03.071
,2019, 'The gut virome: the ‘missing link’ between gut bacteria and host immunity?', Therapeutic Advances in Gastroenterology, 12, http://dx.doi.org/10.1177/1756284819836620
,2019, 'Comparative genomics and genome biology of Campylobacter showae', Emerging Microbes and Infections, 8, pp. 827 - 840, http://dx.doi.org/10.1080/22221751.2019.1622455
,2019, 'Impact of the gastrointestinal microbiome in health and disease: Co-evolution with the host immune system', , 421, pp. 303 - 318, http://dx.doi.org/10.1007/978-3-030-15138-6_12
,2019, 'Volatile organic compounds emitted from faeces as a biomarker for colorectal cancer', Alimentary Pharmacology and Therapeutics, 49, pp. 1005 - 1012, http://dx.doi.org/10.1111/apt.15140
,